1. Home
  2. ACDC vs CDNA Comparison

ACDC vs CDNA Comparison

Compare ACDC & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProFrac Holding Corp.

ACDC

ProFrac Holding Corp.

HOLD

Current Price

$3.91

Market Cap

703.6M

Sector

Energy

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$19.32

Market Cap

712.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACDC
CDNA
Founded
2014
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
703.6M
712.2M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
ACDC
CDNA
Price
$3.91
$19.32
Analyst Decision
Hold
Buy
Analyst Count
3
7
Target Price
$5.83
$26.67
AVG Volume (30 Days)
1.3M
841.8K
Earning Date
11-10-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.22
Revenue
$1,960,000,000.00
$357,998,000.00
Revenue This Year
N/A
$14.11
Revenue Next Year
N/A
$12.00
P/E Ratio
N/A
$16.01
Revenue Growth
N/A
14.46
52 Week Low
$3.08
$10.96
52 Week High
$10.70
$25.95

Technical Indicators

Market Signals
Indicator
ACDC
CDNA
Relative Strength Index (RSI) 44.61 60.43
Support Level $3.78 $19.21
Resistance Level $4.64 $20.05
Average True Range (ATR) 0.28 0.89
MACD -0.02 -0.07
Stochastic Oscillator 22.31 61.97

Price Performance

Historical Comparison
ACDC
CDNA

About ACDC ProFrac Holding Corp.

ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. The company operates in three segments: Stimulation Services, Proppant Production, and Manufacturing. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: